Mehmet Kayaalp

10PUBLICATIONS
91CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersPacific Peoples cultural determinants of healthInfectious diseasesOtorhinolaryngology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 15, 2026
Real-World Outcomes and Prognostic Factors in Patients with Radioiodine-Refractory Differentiated Thyroid Cancer Treated with Sorafenib: A Multicenter Study.

|Jun 29, 2026
Adjuvant Chemotherapy Regimens in Resected Biliary Tract Cancers: National, Comparative, Observational Study (TOG/GI-SAFRADJU-2501).

|Apr 14, 2026
CEA and CA-19-9 Dynamics Associate with Survival in Regorafenib-Treated Metastatic Colorectal Cancer: A Real-World Analysis.

Merih Yalçıner, Mehmet Berk Örüncü, Mehmet Kayaalp

|Mar 26, 2026
Resectable Stage Early-Onset Biliary Tract Cancer: Survival and Prognostic Scoring (EOB-RS and EOB-OS) in Turkish Patients (TOG/GI-SAFRADJU-2502-EO).

Erman Akkus, Mehmet Kayaalp, Müzeyyen Aslı Ergözoğlu

|Feb 13, 2026
Vaccination in patients with cancer: Gaps in coverage, barriers, and the role of clinician recommendations.

Mehmet Kayaalp, Erman Akkuş, Çağatay Arslan

|Nov 27, 2025
Individualized Triplet Chemotherapy Decision-Making in Metastatic Colorectal Cancer: A Machine-Learning-Driven Study.

Mehmet Kayaalp, Erman Akkuş, Beliz Bahar Karaoğlan

Pageof 2

Frequent Collaborators

3 joint publications

Abdulsamet Erden

3 joint publications

Ahmet Omma

3 joint publications

Hatime Arzu Yaşar

2 joint publications

Hakan Apaydin